EMA's access to documents policy would have failed to prevent cases of withheld information
This article was originally published in SRA
Executive Summary
As part of its attempts to improve transparency, the European Medicines Agency has adopted a new policy on increasing public access to documents1. However, delegates at the recent EMA/TOPRA meeting in London2 said that it would not have prevented certain instances where information had been withheld from the public.